Scarica l'app Stockscreener
23.94
3.91%
0.90
Dopo l'orario di chiusura:
23.47
-0.47
-1.96%
Precedente Chiudi:
$23.04
Aprire:
$23.39
Volume 24 ore:
527.21K
Relative Volume:
0.70
Capitalizzazione di mercato:
$1.44B
Reddito:
$439.00K
Utile/perdita netta:
$-105.64M
Rapporto P/E:
-13.30
EPS:
-1.8
Flusso di cassa netto:
$-60.70M
1 W Prestazione:
+3.86%
1M Prestazione:
+0.13%
6M Prestazione:
-20.17%
1 anno Prestazione:
-46.17%
Intervallo 1D:
$22.80
$23.98
Intervallo di 1 settimana:
$22.41
$23.98
Portata 52W:
$21.97
$71.71
Janux Therapeutics Inc Stock (JANX) Company Profile
Nome
Janux Therapeutics Inc
Settore
Industria
Telefono
(858) 751-4493
Indirizzo
10955 VISTA SORRENTO PARKWAY, SAN DIEGO
Confronta JANX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JANX
Janux Therapeutics Inc
|
23.94 | 1.37B | 439.00K | -105.64M | -60.70M | -1.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-07-11 | Iniziato | Raymond James | Outperform |
| 2024-12-03 | Reiterato | BTIG Research | Buy |
| 2024-12-03 | Reiterato | H.C. Wainwright | Buy |
| 2024-11-22 | Iniziato | Leerink Partners | Outperform |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-09-06 | Iniziato | Stifel | Buy |
| 2024-05-30 | Iniziato | Scotiabank | Sector Perform |
| 2024-03-21 | Iniziato | BTIG Research | Buy |
| 2024-03-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-06 | Iniziato | Wedbush | Outperform |
| 2022-11-14 | Iniziato | William Blair | Outperform |
Mostra tutto
Janux Therapeutics Inc Borsa (JANX) Ultime notizie
Why Janux Therapeutics Inc. is moving todayQuarterly Earnings Summary & Real-Time Volume Analysis - Newser
Predicting Janux Therapeutics Inc. trend using moving averagesWeekly Trade Review & High Conviction Buy Zone Alerts - Newser
Real time breakdown of Janux Therapeutics Inc. stock performanceEarnings Summary Report & Fast Moving Trade Plans - Newser
What momentum shifts mean for Janux Therapeutics Inc.2025 Trading Volume Trends & Fast Moving Trade Plans - Newser
Strategies to average down on Janux Therapeutics Inc.Market Sentiment Review & Entry Point Confirmation Signals - Newser
Key metrics from Janux Therapeutics Inc.’s quarterly dataJuly 2025 Movers & Comprehensive Market Scan Insights - Newser
Multi asset correlation models including Janux Therapeutics Inc.Portfolio Gains Summary & High Accuracy Trade Signal Alerts - Newser
Can momentum traders help lift Janux Therapeutics Inc.July 2025 Market Mood & Precise Entry and Exit Recommendations - Newser
Sentiment analysis tools applied to Janux Therapeutics Inc.July 2025 Chart Watch & Safe Entry Point Identification - Newser
Can Janux Therapeutics Inc. disrupt its industryBond Market & Real-Time Volume Analysis Alerts - khodrobank.com
Custom watchlist performance reports with Janux Therapeutics Inc.Quarterly Earnings Summary & Smart Swing Trading Techniques - Newser
How to recover losses in Janux Therapeutics Inc. stockEarnings Overview Report & Low Drawdown Trading Techniques - Newser
Is Janux Therapeutics Inc.’s ROIC above industry averageMarket Sentiment Summary & Consistent Profit Trading Strategies - khodrobank.com
Risk adjusted return profile for Janux Therapeutics Inc. analyzedJuly 2025 Decliners & Capital Efficient Trade Techniques - Newser
Is Janux Therapeutics Inc. showing signs of accumulationRate Hike & Fast Exit Strategy with Risk Control - Newser
Published on: 2025-09-02 13:17:12 - Newser
Can a trend reversal in Janux Therapeutics Inc. lead to recoveryFed Meeting & Technical Confirmation Alerts - Newser
Janux Therapeutics Inc. stock daily chart insightsWeekly Trend Summary & Fast Entry High Yield Stock Tips - Newser
Published on: 2025-09-02 03:50:49 - Newser
Tick level data insight on Janux Therapeutics Inc. volatility2025 Sector Review & Consistent Profit Trading Strategies - Newser
Can you recover from losses in Janux Therapeutics Inc.2025 Top Gainers & Free Technical Pattern Based Buy Signals - Newser
How to use a screener to detect Janux Therapeutics Inc. breakoutsEarnings Recap Report & Long-Term Safe Investment Ideas - Newser
Is it too late to sell Janux Therapeutics Inc.Treasury Yields & Community Verified Trade Alerts - Newser
Published on: 2025-09-01 15:48:42 - Newser
Werewolf Therapeutics’s SWOT analysis: innovative platform drives stock potential - Investing.com
Why is Janux Therapeutics Inc. stock going downStop Loss & Reliable Volume Spike Alerts - khodrobank.com
Market Recap: Why is Janux Therapeutics Inc. stock going upWeekly Trend Report & Free Long-Term Investment Growth Plans - خودرو بانک
How to integrate Janux Therapeutics Inc. into portfolio analysis toolsEarnings Overview Report & Long-Term Growth Portfolio Plans - Newser
Tools to assess Janux Therapeutics Inc.’s risk profileCPI Data & Weekly Top Performers Watchlists - Newser
Has Janux Therapeutics Inc. formed a bullish divergenceQuarterly Earnings Report & Real-Time Volume Analysis - Newser
Janux Therapeutics Inc. Included in Top Momentum ScanQuarterly Performance Summary & Weekly Setup with High ROI Potential - beatles.ru
Options Data Show Bullish Bias in Janux Therapeutics Inc.Market Activity Report & Weekly Setup with High ROI Potential - beatles.ru
Published on: 2025-08-30 20:43:08 - Newser
Janux Therapeutics Inc Azioni (JANX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Janux Therapeutics Inc Azioni (JANX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Meyer Andrew Hollman | Chief Business Officer |
May 01 '25 |
Sale |
32.03 |
3,333 |
106,745 |
82,139 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):